In the third quarter of 2025 Coulter Partners drove global executive search for a wide range of life sciences, health, and technology organizations.

We successfully placed executives for independent and VC & PE-backed firms, alongside large-cap and mid-cap public companies, filling critical roles across diverse disciplines worldwide.

CEO/ C-suite/ Board

• CEO, Diagnostic & laboratory services (PE-backed), France
• CEO, Small-molecule therapies (VC-backed), Italy
• CEO, Bio-storage solutions (PE-backed), UK
• CEO, Cell & gene therapies (VC-backed), Denmark
• Chief Financial Officer, Medical devices (VC-backed), France
• Chief Financial Officer, Cell therapies (Publicly listed), US
• Chief Scientific Officer, tRNA platform company (VC-backed), US
• Chief Scientific Officer, Protein degrader therapeutics (VC-backed), Italy
• Chief Business Officer, Regenerative macrophage therapies (VC-backed), US
• Chief Business Officer, Pediatric medicines (VC-backed), UK
• Chief Operating Officer, Industry catapult (Not-for-Profit), UK
• Chair, Contract Research Organization (Publicly listed), UK
• Board Director, Regulatory T cells (Tregs) (VC-backed), US
• Board Director, Small-molecule inhibitors (VC-backed), US
• Board Director, APIs (Independently-owned), Spain

Commercial/Functional/Strategic

• VP, Commercial Strategy International, Specialty pharma (Publicly listed), US / UK
• Country CEO, Dental services (PE-backed), Denmark
• Country CEO, Engineering consultancy services (PE-backed), Norway
• Global Head of Communications, Generics (Publicly listed), UK
• General Manager, APIs / Pharma (Family-owned), Italy
• Country General Manager, Biopharma (Publicly listed), Australia
• Country General Manager, Medical instrumentation (Family-owned), UK
• Market Access Director, Specialty pharma (Independently-owned), France
• Region Finance Director, Medical devices (PE-backed), Sweden
• Sales Managers, Pharma capex solutions (PE-backed), US

R&D/Medical/Technical

• SVP, Quality, Pharmaceutical services (PE-backed), Ireland
• VP, International Regulatory Strategy, Specialty biopharma (Publicly listed), UK
• VP, CMC, MASH therapeutics (Publicly listed), US
• VP, Global Medical Affairs, Obesity, Top 10 global pharma (Publicly listed), Denmark / US
• AVP, Technical Operations, Organ manufacturing (Publicly listed), US
• Global Head Biometric Sciences, Specialty pharma (Family-owned), Switzerland
• Global Head Toxicology Services, Laboratory services (PE-backed), Germany
• Market Value & Evidence Lead, Specialty pharma (Family-owned), Italy
• Head of Pharmacovigilance, Drug discovery (Publicly listed), Switzerland
• Global R&D Director, Wound care products (PE-backed), Germany
• Executive Medical Director, Obesity, Top 10 global pharma (Publicly listed), US
• Industrial Director, Specialty ingredients (PE-backed), France